NCT00639678 - A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects | Biotech Hunter

Enrollment

322

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions

Healthy

Interventions

DRUG

placebo

40 mg/kg intravenously, double dose (day 0 and 14), Group 3

DRUG

raxibacumab

40 mg/kg intravenously, double dose (day 0 and 14), Group 1

DRUG

placebo

40 mg/kg placebo, single dose (day 0), Group 4

DRUG

raxibacumab

40 mg/kg intravenously, single dose, day 0, Group 2